Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00193661 · ClinicalTrials.gov registry record · Phase 2
Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism
A Phase 2 study, sponsored by Solvay Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00193661: Completed Phase 2 study, sponsored by Solvay Pharmaceuticals.
NCT00193661 is a Phase 2 study that has completed, run by Solvay Pharmaceuticals. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00193661, a Phase 2 study, has completed, sponsored by Solvay Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
This study is to observe efficacy and safety after T-Gel 1% treatment in delayed puberty adolescents. Subjects who complete this trial may enter a 3 month extension study (UMD-01-090E).
Interventions
- DRUG Testosterone Gel (1%)
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-08 |
| Est. Completion | 2007-03 |
| Phase | Phase 2 |
What the finished NCT00193661 record still lists
NCT00193661 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Testosterone Gel (1%) is the first listed.
NCT00193661 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00193661 about?
NCT00193661 is a clinical study titled "Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism". This study is to observe efficacy and safety after T-Gel 1% treatment in delayed puberty adolescents. Subjects who complete this trial may enter a 3 month extension study (UMD-01-090E).
What is the current status of trial NCT00193661?
This trial is currently completed. It is a Phase 2 study. The study started on 2002-08. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00193661?
The interventions under investigation include: Testosterone Gel (1%) (DRUG).
Who is sponsoring clinical trial NCT00193661?
This trial is sponsored by Solvay Pharmaceuticals, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia